This inventor holds 1 USPTO granted patent. Top assignee: Zenyaku Kogyo Kabushiki Kaisha. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: The Innovations of Tomoyoshi Kayou
Introduction
Tomoyoshi Kayou is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. His innovative work has led to the creation of a novel purine derivative that holds promise for cancer treatment.
Latest Patents
Tomoyoshi Kayou holds a patent for a purine derivative and an antitumor agent utilizing the same. The patent discloses a compound represented by a specific formula, along with its pharmaceutically acceptable salts, solvates, or hydrates. This invention outlines a method for treating tumors using the purine derivative, showcasing its potential as an effective antitumor agent.
Career Highlights
Kayou is associated with Zenyaku Kogyo Kabushiki Kaisha, a company known for its focus on pharmaceutical innovations. His work at the company has been instrumental in advancing research and development in cancer therapies.
Collaborations
Throughout his career, Tomoyoshi Kayou has collaborated with notable colleagues, including Toshiaki Suzuki and Hideki Satoh. These partnerships have fostered a collaborative environment that enhances the innovation process.
Conclusion
Tomoyoshi Kayou's contributions to the field of pharmaceuticals, particularly through his patent on a purine derivative, highlight his role as a key innovator in cancer treatment. His work continues to inspire advancements in medical research and development.